TransMedics Secures $36M Round of Financing

TransMedics, Inc., an Andover, Massachusetts-based medical device company focusing on delivering a system which maintains donor organs in functioning condition during transport, completed a $36m financing round.
The financing was lead by Foundation Capital and Kleiner Perkins Caufield & Byers (KPCB), with participation from Flagship Ventures and existing investors.
TransMedics is the maker of the Organ Care System – OCS (TM) – a technology platform which maintains donor organs in near-physiologic and functioning condition during transport for organ transplantation.
As also stated by Dr. Waleed Hassanein, President and CEO of TransMedics, Inc. this financing enables the company to expand its commercial presence into the US market with the heart OCS(TM) device and to globally launch the OCS(TM) lung device over the next two years.

Join the discussion